Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prothrombin complex concentrate for progressive hemorrhagic injury after traumatic brain injury
ChiCTR2000035784Phase 3Not yet recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Jan 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in traumatic brain injury (TBI), intracerebral hemorrhage (ICH) and progressive hemorrhagic injury (PHI) comparing Prothrombin complex concentrate with Placebo (2 arms). Primary endpoint: Percent change in volume of intraparenchymal contusion and hemorrhage. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
prothrombin complex concentrate, human
03
Conditions
traumatic brain injury (TBI)intracerebral hemorrhage (ICH)progressive hemorrhagic injury (PHI)
Beyond the preview
Go deeper on ChiCTR2000035784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035784.